European Archives - Page 1158 of 1193 - European Medical Journal

Small Intestinal Tumours: An Overview on Classification, Diagnosis, and Treatment

The small intestinal neoplasia group includes different types of lesions and are a relatively rare event, accounting for only 3-6% of all…

The Geographic Variance of Helicobacter Pylori Infection in Europe and its Impact on the Incidence of Gastric Cancer

The discovery of Helicobacter pylori was hopeful as this agent was included in the list of ‘preventable- infectious carcinogens’, and many non-treatable…

Managing Complicated Diverticular Disease in 2014

Complicated diverticular disease refers to patients who present with abscess, peritonitis, bleeding, fistula, or bowel obstruction. Management paradigms…

Understanding Exercise-Associated Hyponatraemia: From Pathophysiology to Treatment

The practice of extreme sports is becoming more and more common. Despite physiological adaptation, people who intensively exercise are exposed to…

EMJ Gastroenterology 3.1 2014

Innovation, best-practice, improving patient outcomes and quality of life, and new endeavours are all areas which this edition of European Medical…

EMJ

UEG Puts the Need for Better Care for IBD Patients in Europe on the Political Agenda

(Vienna, 02, December, 2014) With inflammatory bowel disease (IBD) thought to cost the European Community over €2 billion in annual healthcare costs…

Inherited Bone Marrow Failure Syndromes with Pancytopaenia

Bone marrow failure (BMF) is characterised by a reduction in the effective production of mature erythrocytes, granulocytes, and platelets by the bone…

EMJ

Infecciones urinarias recurrentes: resistencia a los antibióticos y directrices

La aparición y propagación de la resistencia a los antibióticos (RAB) es un factor crítico en la salud general y el bienestar. Debido a su prevalencia…

EMJ

Introducción a la carga que supone la cystitis recurrente y la justificación de la prevención

Esta cumbre, de carácter educativo y financiada por una beca independiente de OM/Vifor Pharma, ha reunido a expertos en urología y ginecología procedentes…

EMJ

Infecciones urinarias en grupos de población específicos y polémica en torno al tratamiento de la enfermedad

Resumen de las presentaciones seleccionadas de la cumbre OM Pharma/ViforPharma URO-VAXOM® celebrada en Buenos Aires (Argentina) los días 26 y 27 de abril de 2014